Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Dermatitis : Contact, Atopic, Occupational, Drug|September 27, 2012
T-cell inhibitors: a bench-to-bedside reviewShinjita Das, Kiyoshi Ariizumi, Ponciano D CruzEuropean Journal of Immunology|April 7, 2011
Inhibition of T-cell activation by syndecan-4 is mediated by CD148 through protein tyrosine phosphatase activityJin-Sung Chung, Ponciano D Cruz, Kiyoshi AriizumiGlycobiology|March 17, 2009
Recognition of non-self-polysaccharides by C-type lectin receptors dectin-1 and dectin-2S Tyler Hollmig, Kiyoshi Ariizumi, Ponciano D CruzPhotodermatology, Photoimmunology & Photomedicine|May 2, 2002
Genomic scale analysis of the human keratinocyte response to broad-band ultraviolet-B irradiationJoe Takao, Kiyoshi Ariizumi, Irene I Dougherty, et al.The Journal of Investigative Dermatology|October 25, 2021
Soluble DC-HIL/Gpnmb Modulates T-Lymphocyte Extravasation to Inflamed SkinVijay Ramani, Jin-Sung Chung, Kiyoshi Ariizumi, et al.The Journal of Investigative Dermatology|June 18, 2014
DC-HIL-expressing myelomonocytic cells are critical promoters of melanoma growthJin-Sung Chung, Kyoichi Tamura, Ponciano D Cruz, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activationJin-Sung Chung, Irene Dougherty, Ponciano D Cruz, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 12, 2014
The DC-HIL/syndecan-4 pathway regulates autoimmune responses through myeloid-derived suppressor cellsJin-Sung Chung, Kyoichi Tamura, Hideo Akiyoshi, et al.European Journal of Immunology|April 8, 2009
The DC-HIL/syndecan-4 pathway inhibits human allogeneic T-cell responsesJin-Sung Chung, Makoto Bonkobara, Mizuki Tomihari, et al.Cancer Research|June 24, 2010
DC-HIL/glycoprotein Nmb promotes growth of melanoma in mice by inhibiting the activation of tumor-reactive T cellsMizuki Tomihari, Jin-Sung Chung, Hideo Akiyoshi, et al.Pageof 4